Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib

Pedram Gerami; Jennifer Sorrell; Mary Martini

doi:10.1016/j.jaad.2012.05.031

Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib

Pedram Gerami^*, Jennifer Sorrell, Mary Martini

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Original language	English (US)
Pages (from-to)	e275-e276
Journal	Journal of the American Academy of Dermatology
Volume	67
Issue number	6
DOIs	https://doi.org/10.1016/j.jaad.2012.05.031
State	Published - Dec 2012

Funding

Disclosure: Dr Gerami has served as a consultant to Abbott Molecular Labs and Neogenomics and has received honoraria for this. This work was supported by the Dermatology Foundation and the American Cancer Society , IL Division (Sponsored Reference Award#: 160272 ). Dr Martini has served on the advisory board of Dove-Unilever and has received honoraria for this. She has also been an investigator for Melasciences Inc.

ASJC Scopus subject areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaad.2012.05.031

Cite this

@article{07d390d4c29e4e84825a4349611f5906,

title = "Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib",

author = "Pedram Gerami and Jennifer Sorrell and Mary Martini",

note = "Funding Information: Disclosure: Dr Gerami has served as a consultant to Abbott Molecular Labs and Neogenomics and has received honoraria for this. This work was supported by the Dermatology Foundation and the American Cancer Society , IL Division (Sponsored Reference Award#: 160272 ). Dr Martini has served on the advisory board of Dove-Unilever and has received honoraria for this. She has also been an investigator for Melasciences Inc. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",

year = "2012",

month = dec,

doi = "10.1016/j.jaad.2012.05.031",

language = "English (US)",

volume = "67",

pages = "e275--e276",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib

AU - Gerami, Pedram

AU - Sorrell, Jennifer

AU - Martini, Mary

N1 - Funding Information: Disclosure: Dr Gerami has served as a consultant to Abbott Molecular Labs and Neogenomics and has received honoraria for this. This work was supported by the Dermatology Foundation and the American Cancer Society , IL Division (Sponsored Reference Award#: 160272 ). Dr Martini has served on the advisory board of Dove-Unilever and has received honoraria for this. She has also been an investigator for Melasciences Inc. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.

PY - 2012/12

Y1 - 2012/12

UR - http://www.scopus.com/inward/record.url?scp=84867928898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867928898&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2012.05.031

DO - 10.1016/j.jaad.2012.05.031

M3 - Article

C2 - 23158636

AN - SCOPUS:84867928898

SN - 0190-9622

VL - 67

SP - e275-e276

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 6

ER -

Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this